EHA 2018 prof. dr. S. Verstovsek - JUMP low risk

Prof. dr. Srdan Verstovsek, MD Anderson Houston (US)

 

SAFETY AND EFFICACY OF RUXOLITINIB (RUX) IN PATIENTS (PTS) WITH DIPSS LOW-RISK MYELOFIBROSIS (MF) IN THE PHASE 3B EXPANDED-ACCESS JUMP STUDY

 

Bekijk het abstract  

 

Click here for the prescribing information of Jakavi
 

0718HEM989458
×

Ask Speakers

×

Medical Information Request